Solopharm has been named a finalist for the 12th «Green Cross» Pharmaceutical Award, one of the most prominent professional awards in the Russian pharmaceutical market. Following the results of the first voting stage, the company and its representatives have been shortlisted in several key categories.
The second voting stage is now underway and will run through June 19, 2026, inclusive.
The following have advanced to the award finals:
«Pharmaceutical Company» category
-
Solopharm
«Pharmacy Spider» category
(Best pharmaceutical company manager working with pharmacy chains)
-
Maxim Dunaev, Commercial Director of Solopharm
«OTC Product» category
-
Trekrezan®
Reaching the award finals is an important recognition of the company's efforts by the professional pharmaceutical community, pharmacy chain representatives, distributors, and industry experts.
The «Green Cross» Award annually brings together leading players in the pharmaceutical market and serves to recognize companies, products, and professionals who make a significant contribution to the industry's development and to shaping high standards of interaction between manufacturers, pharmacy chains, and consumers.
We thank all our partners, colleagues, and market participants for the trust and support shown during the first voting stage.
We invite you to take part in the second stage and support Solopharm, Maxim Dunaev, and the Trekrezan® brand.
You can vote via the link
https://docs.google.com/forms/d/e/1FAIpQLSc6u8weiXrEu-AJEvtPcI1NGF2ywfMTS0FsJwgvIZp2UOinVg/viewform
The winners of the 12th «Green Cross» Pharmaceutical Award will be announced during the 28th "Green Cross" Conference, to be held on June 25–26, 2026, in St. Petersburg.
The conference is traditionally one of the largest professional platforms in the pharmaceutical industry, annually gathering representatives of pharmacy chains, pharmaceutical companies, and distributors from across the country. This year, around 400 delegates have already registered for the event.
The conference program includes industry discussions, analytical reviews, practical case studies, masterclasses, training sessions, and meetings with leading pharmaceutical market experts.
We thank everyone and look forward to your support in the final voting stage!
.jpg)